New Jersey · 96417

Administration Of Additional New Drug Or Substance Into Vein, 1 Hour Or Less in New Jersey

New Jersey Medicare Avg
$57.70
14% above national avg
National Medicare Avg
$50.77
All states combined
Billed Charge (NJ)
$241.44
What providers submit
Est. Commercial (NJ)
$184.68
National avg: $137.32
Est. Cash / Self-Pay (NJ)
$120.71
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

9.2K
Services in NJ
156
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in New Jersey

Provider Medicare Services
Fleming, Elizabeth NP $48.16 261
Shah, Chirag MD $57.59 246
Lindenberg, Noah MD $58.06 244
Abdo-Matkiwsky, May D.O. $59.56 232
Nahum, Kenneth D.O. $56.53 230
Chatiwala, Jumana M.D. $58.78 227
Agrawal, Apurv M.D. $57.75 214

New Jersey Pricing in Context

In New Jersey, CPT code 96417 (Administration Of Additional New Drug Or Substance Into Vein, 1 Hour Or Less) carries an average Medicare payment of $57.70 — 14% above the national benchmark of $50.77. 156 providers across the state submitted claims for this procedure in 2023, performing 9.2K total services. Individual payments in NJ ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in New Jersey is $241.44, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because New Jersey sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Medicine procedures, the estimated commercial insurance price in New Jersey lands near $184.68, with self-pay cash prices typically around $120.71. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Administration Of Additional New Drug Or Substance Into Vein, 1 Hour Or Less cost in New Jersey?

The average Medicare payment for Administration Of Additional New Drug Or Substance Into Vein, 1 Hour Or Less in New Jersey is $57.70, which is 14% above the national average of $50.77. Providers in NJ typically bill $241.44 for this procedure.

What does Administration Of Additional New Drug Or Substance Into Vein, 1 Hour Or Less cost with insurance in New Jersey?

With commercial insurance in New Jersey, Administration Of Additional New Drug Or Substance Into Vein, 1 Hour Or Less costs an estimated $184.68. Without insurance, the estimated cash price is $120.71. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Administration Of Additional New Drug Or Substance Into Vein, 1 Hour Or Less in New Jersey?

156 providers in New Jersey billed Medicare for Administration Of Additional New Drug Or Substance Into Vein, 1 Hour Or Less in 2023, performing 9.2K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Administration Of Additional New Drug Or Substance Into Vein, 1 Hour Or Less cheaper in New Jersey than the national average?

No — Administration Of Additional New Drug Or Substance Into Vein, 1 Hour Or Less costs 14% above the national average in New Jersey. The state average Medicare payment is $57.70 compared to $50.77 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial